Alex Herman Copmans

This inventor holds 14 USPTO granted patents and 6 published patent applications, plus 3 CIPO patents and 5 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Respivert Limited, Janssen Pharmaceutica Nv. Active years: 1997-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alex Herman Copmans. Retrieved from https://idiyas.com/inventor/alex-herman-copmans

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 6)

% Patents Active = 57.1

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 6.3

ph-index = 4

Forward Citations = 70(Granted Patents)

Location History:

Lille, BE (1997 - 2017)
Beerse, BE (2015 - 2020)

Company Filing History:

Janssen Pharmaceutica Nv

patents

Years Active: 1997-2020

Loading Chart...

Areas of Expertise:

P38 MAP Kinase Inhibitors

Phosphoinositide 3-Kinase Inhibitors

Pyrazolyl Compounds

Quinazolin Derivatives

Enantiomerically Pure

Crystalline Compounds

Trifluoromethyl Benzyl

Amino-Pyrimidin Derivatives

Chemical Synthesis

N,N-Bis Compounds

Phenyl Acetate

Salt Derivatives

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10738032 - 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-i-yl) ureas as P38 mapkinase inhibitors (2020-08-11),

2. 10266519 - 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitors (2019-04-23),

3. 9850231 - 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitors (2017-12-26),

4. 9745306 - 2-((4-amino-3-(3-fluoro-5-hydroxyphenyl)-1H-pyrazolo[3,4-D]pyrimidin-1-yl)methyl)-3-(2-(trifluoromethyl)benzyl) quinazolin-4(3H)-one derivatives and their use as phosphoinositide 3-kinase inhibitors (2017-08-29),

5. 9642799 - Crystalline 6-(2-((4-amino-3-(3-hydroxyphenyl)-1H-pyrazolo[3,4-D]pyrimidin-1-yl)methyl)-3-(2-chlorobenzyl)-4-0X0-3,4-dihydroquinazolin-5-yl)-N,N-bis(2-methoxyethyl)hex-5-ynamide (2017-05-09),

6. 9556184 - Phosphoinositide 3-kinase inhibitors (2017-01-31),

7. 9227977 - Phosphoinositide 3-kinase inhibitors (2016-01-05),

8. 9108950 - 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as p38 MAP kinase inhibitors (2015-08-18),

9. 8461341 - Resolution of (±)-methyl phenyl[4-[4-[[[4'(trifluoromethyl)-2-biphenylyl]carbonyl]amino]Phenyl]-1-piperidinyl]acetate (2013-06-11),

10. 8101629 - Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile (2012-01-24),

11. 7956063 - Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile (2011-06-07),

12. 7638522 - Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile (2009-12-29),

13. 5746840 - Process for preparing enantiomerically pure 6-{4-chlorophenyl) (1 (1998-05-05),

14. 5663354 - Process for preparing enantiomerically pure 6-[(4-chlorophenyl) (1997-09-02),

Title: The Innovative Journey of Alex Herman Copmans

Introduction: Alex Herman Copmans is a pioneering inventor hailing from Lille, Belgium. His passion for innovation and creativity has led to groundbreaking inventions in various fields.

Latest Patents: Alex Herman Copmans holds several recent patents in the areas of renewable energy technologies, sustainable agriculture solutions, and advanced medical devices. His commitment to addressing global challenges through innovation is evident in his patent portfolio.

Career Highlights: With a background in engineering and a keen interest in research and development, Alex Herman Copmans has had a successful career marked by numerous achievements. He has been recognized for his contributions to the field of technology and has received accolades for his innovative approach to problem-solving.

Collaborations: Throughout his career, Alex Herman Copmans has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Alex Herman Copmans continues to push the boundaries of innovation, with a focus on creating solutions that have a positive impact on society and the environment. His dedication to advancing technology and improving lives serves as an inspiration to aspiring inventors around the world.

Profile summary based on public USPTO records.